A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story
The Big Market Report Take
Bausch + Lomb, a global leader in eye health products and surgical devices, reported a recent insider buy amid ongoing sector activity.
Not financial advice. The Big Market Report aggregates news for informational purposes only. Nothing on this site constitutes investment advice. Equities and other securities are subject to market risk. Always do your own research and consult a qualified financial advisor before making any investment decisions. Full disclaimer →
Never miss a story
More from this section
- Sixth Street Specialty Lending: Sustainable Dividend But Lacks Growth CatalystSeeking Alpha29m ago
- NZ Fin Min Willis on Economic Outlook Amid Iran WarBloomberg Markets30m ago
- Trump Says Iran 'Wants to Make a Deal' As Costs RiseBloomberg Markets40m ago
- Silver And Gold Intraday Outlook: The Metals Space Is As Confused As Traders AreSeeking Alpha42m ago
Why Meta Stock Could Fall Even FurtherThe Motley Fool52m ago